Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.

Mast AS, Lang P, Schlegel P, Calkoen FG, Atar D, Scheuermann S, Klein S, Braun C, Schinle F, Schmidt M, Hensen L, Ebinger M, Döring M, Schäfer JF, Schulte J, Bethge WA, Lengerke C, Alahmari B, Hu P, Schneider D, Orentas RJ, Handgretinger R, Seitz CM

Open source

DOI: 10.1136/jitc-2025-013901
Published: 2026 May 21
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-013901,
  title = {Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.},
  author = {Mast AS and Lang P and Schlegel P and Calkoen FG and Atar D and Scheuermann S and Klein S and Braun C and Schinle F and Schmidt M and Hensen L and Ebinger M and Döring M and Schäfer JF and Schulte J and Bethge WA and Lengerke C and Alahmari B and Hu P and Schneider D and Orentas RJ and Handgretinger R and Seitz CM},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-013901},
  url = {https://doi.org/10.1136/jitc-2025-013901}
}

RIS

TY  - JOUR
TI  - Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.
AU  - Mast AS
AU  - Lang P
AU  - Schlegel P
AU  - Calkoen FG
AU  - Atar D
AU  - Scheuermann S
AU  - Klein S
AU  - Braun C
AU  - Schinle F
AU  - Schmidt M
AU  - Hensen L
AU  - Ebinger M
AU  - Döring M
AU  - Schäfer JF
AU  - Schulte J
AU  - Bethge WA
AU  - Lengerke C
AU  - Alahmari B
AU  - Hu P
AU  - Schneider D
AU  - Orentas RJ
AU  - Handgretinger R
AU  - Seitz CM
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-013901
UR  - https://doi.org/10.1136/jitc-2025-013901
ER  -

APA

AS, M., P, L., P, S., FG, C., D, A., S, S., S, K., C, B., F, S., M, S., L, H., M, E., M, D., JF, S., J, S., WA, B., C, L., B, A., P, H., D, S., RJ, O., R, H., & CM, S. (2026). Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-013901

Source records

pubmed · retrieved 2026-09-26T09:39:25.403Z